Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy


ISSN: 2253-1556

Editor-in-Chief: Dr Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 


Indexed online:

Latest articles:

- 5 records -

TNFR2: Role in Cancer Immunology and Immunotherapy

Yang Y, Islam MS, Hu Y, Chen X

ImmunoTargets and Therapy 2021, 10:103-122

Published Date: 21 April 2021

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F

ImmunoTargets and Therapy 2021, 10:63-85

Published Date: 9 March 2021

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

Barros PO, Berthoud TK, Aloufi N, Angel JB

ImmunoTargets and Therapy 2021, 10:47-62

Published Date: 8 March 2021

Anti-IgE for the Treatment of Chronic Urticaria

Wedi B, Traidl S

ImmunoTargets and Therapy 2021, 10:27-45

Published Date: 17 February 2021

 

Read more articles